Diabetes decisions — 2024

The Veteran's TDIU claim is remanded due to a duty-to-assist error. A VA examiner will be needed to assess the functional impact of his service-connected disabilities on his employability.

The Veteran's TDIU claim was granted in a November 2023 rating decision, effective May 11, 2022. The appeal for this issue is dismissed as the award has already been made.

The Board has denied service connection for COPD, diabetes mellitus, left shoulder joint pain, right shoulder joint pain, and hypertension/vasovagal syndrome. The remaining issues have been remanded due to the need for additional medical examinations.

The Veteran's service-connected diabetes mellitus has been rated at 20 percent since April 16, 2018. The left and right upper extremity diabetic peripheral neuropathy have also been granted with a 20 percent rating effective January 21, 2022. However, the Veteran is denied higher ratings for these conditions.

The Board has remanded the cases for additional development due to incomplete medical records and need for a comprehensive VA medical opinion.

The Board has remanded the case due to a need for a medical opinion regarding whether the Veteran's service-connected Parkinson's Disease caused or aggravated his obesity, which in turn may have contributed to his diabetes mellitus.

The Board has dismissed the Veteran's appeals for service connection on all claims due to a full grant of benefits in January and May 2023 rating decisions.

The Board has remanded the case due to conflicting diagnoses and a need for an adequate medical opinion regarding the Veteran's acquired psychiatric disabilities, including PTSD, depression, and unspecified trauma and stressor related disorder.

The Board has found that the Veteran's service-connected disabilities do not preclude him from working, but additional evidence is needed to determine his ability to maintain gainful employment due to these conditions.

The Board granted service connection for diabetes mellitus type II, finding the Veteran was exposed to herbicide agents during his service in Thailand and that his condition manifested to a degree of 10 percent or more.

The Board denied the Veteran's claim for service connection for diabetes mellitus type II and impaired glucose tolerance, finding that there was no evidence of a current disability or a relationship to service.

The Veteran withdrew his appeal regarding the claims of service connection for diabetes mellitus type II and ischemic heart disease.

The Veteran's service-connected disabilities, including PTSD, OSA, and peripheral neuropathies, prevented him from securing and maintaining substantially gainful employment as of January 5, 2015. The Board grants TDIU effective that date.

The Veteran's diabetes mellitus, type II is granted service connection based on the PACT Act presumption of herbicide exposure. Service connection for congestive heart failure as secondary to diabetes mellitus, type II, is remanded due to a need for a VA opinion.

The Veteran's entitlement to a rating of 20 percent for diabetic retinopathy, both eyes from May 13, 2018 to January 26, 2021 is granted.

The Veteran's appeals for diabetes mellitus, hypertension, and prostate cancer have been withdrawn. The claims of service connection for residuals of prostate cancer, lung disability (IPF), kidney disease, and IBS are remanded due to new evidence submitted after the prior final rating decisions.

The appeal is remanded for correction of pre-decisional duty to assist errors regarding the severity assessment and treatment records, as well as for adjudication of the TDIU claim.

The Board has dismissed all issues of service connection and increased ratings, as the Veteran withdrew his appeals for these claims during a hearing. The Veteran was granted TDIU.

The Veteran withdrew his claims for service connection for a disorder characterized by abnormal weight/gain, brain damage, chronic fatigue syndrome, chronic muscle and joint pain, diabetes mellitus type II, irritable bowel syndrome, left rotator cuff tear, loss of smell, loss of taste, other specified depressive disorder, skin disorder, umbilical hernia, sleep apnea, and gastroesophageal reflux disease.

The Veteran withdrew his appeal regarding the claims of service connection for diabetes mellitus type II and ischemic heart disease.